Blackstone Inc
RVLP

Blackstone Inc’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Blackstone Inc’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-632,264
Closed -$56.9K – 184
2023
Q3 		$56.9K Buy
+632,264
New +$182K ﹤0.01% 151

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Blackstone Inc's RVLP Position: Q4 2023 in Review

Blackstone Inc sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 632,264 shares — an estimated $56.9K sold.

Blackstone Inc first reported a position in RVLP in Q3 2023 and held it in 1 quarter. The position peaked at $56.9K in Q3 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Blackstone Inc reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Blackstone Inc sold 632,264 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $56.9K.
  • Blackstone Inc first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • Blackstone Inc's RVL Pharmaceuticals plc Ordinary Shares position peaked at $56.9K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Blackstone Inc's 13F filing for Q4 2023, filed 14 Feb 2024.